SC
Stempoint Capital Portfolio holdings
AUM
$496M
1-Year Est. Return
93.41%
1 Year Est. Return
+93.41%
AUM
$496M
AUM Growth
+$185M
(+60%)
Holding
92
Top Buys
| 1 | +$54.4M | |
| 2 | +$14.9M | |
| 3 | +$12.6M | |
| 4 |
argenx
ARGX
|
+$9.19M |
| 5 |
Wave Life Sciences
WVE
|
+$8.86M |
Top Sells
| 1 | +$20.4M | |
| 2 | +$18M | |
| 3 | +$15.6M | |
| 4 |
Syndax Pharmaceuticals
SNDX
|
+$15.5M |
| 5 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$14.8M |
Sector Composition
| 1 | Healthcare | 99.22% |
| 2 | Financials | 0.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IVA
76
Inventiva
IVA
$791M
| $178K | 0.04% |
+30,824
|
|
||
77
Apogee Therapeutics
APGE
$5.09B
| – | – |
-84,466
|
|
||
78
ARK Genomic Revolution ETF
ARKG
$1.24B
| – | – |
0
|
|
||
79
CRISPR Therapeutics
CRSP
$5.34B
| – | – |
0
|
|
||
80
EyePoint Pharmaceuticals
EYPT
$1.2B
| – | – |
-329,254
|
|
||
81
Geron
GERN
$811M
| – | – |
-6,649,244
|
|
||
82
Ionis Pharmaceuticals
IONS
$13.3B
| – | – |
0
|
|
||
83
Janux Therapeutics
JANX
$1.03B
| – | – |
-89,933
|
|
||
84
Legend Biotech
LEGN
$5.13B
| – | – |
-270,144
|
|
||
85
Merus
MRUS
$7.29B
| – | – |
-266,094
|
|
||
86
Nuvalent
NUVL
$8.3B
| – | – |
-59,828
|
|
||
87
Praxis Precision Medicines
PRAX
$4.66B
| – | – |
-32,255
|
|
||
88
Regeneron Pharmaceuticals
REGN
$76.1B
| – | – |
-4,672
|
|
||
|
VRNA
89
DELISTED
Verona Pharma
VRNA
| – | – |
-7,407
|
|
||
90
State Street SPDR S&P Biotech ETF
XBI
$8.08B
| – | – |
0
|
|
||
91
Zai Lab
ZLAB
$2.19B
| – | – |
-250,438
|
|
||
|
LENZ
92
LENZ Therapeutics
LENZ
$876M
| – | – |
-183,912
|
|